Gallbladder Cancer Incidence and Mortality, United States 1999-2011. 2015

S Jane Henley, and Hannah K Weir, and Melissa A Jim, and Meg Watson, and Lisa C Richardson
Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia. shenley@cdc.gov.

BACKGROUND Gallbladder cancer is a rare cancer with unusual distribution, and few population-based estimates for the United States have been published. METHODS Using population-based cancer incidence and mortality data, we examined U.S. gallbladder cancer incidence and death rates for 2007-2011 and trends for 1999-2011. RESULTS During 2007 to 2011, approximately 3,700 persons were diagnosed with primary gallbladder cancer (rate = 1.13 cases per 100,000) and 2,000 died from the disease (rate = 0.62 deaths per 100,000) each year in the United States. Two thirds of gallbladder cancer cases and deaths occurred among women. Gallbladder cancer incidence and death rates were three times higher among American Indian and Alaska Native persons than non-Hispanic white persons. By state, gallbladder cancer incidence and death rates ranged by about 2-fold. During 1999 to 2011, gallbladder cancer incidence rates decreased among women but remained level among men; death rates declined among women but stabilized among men after declining from 1999 to 2006. Gallbladder cancer incidence rates increased in some subgroups, notably among black persons, those aged <45 years, and for endocrine tumors. CONCLUSIONS Data from U.S. population-based cancer registries confirm that gallbladder cancer incidence and death rates are higher among women than men, highest among American Indian and Alaska Native persons, and differ by region. While overall incidence and death rates decreased during 1999 to 2011, incidence rates increased among some small subgroups. CONCLUSIONS Surveillance of gallbladder cancer incidence and mortality, particularly to monitor increases in subgroups, may provide clues to etiology and stimulate further research.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D005706 Gallbladder Neoplasms Tumors or cancer of the gallbladder. Cancer of Gallbladder,Gallbladder Cancer,Cancer of the Gallbladder,Gall Bladder Cancer,Neoplasms, Gallbladder,Bladder Cancer, Gall,Bladder Cancers, Gall,Cancer, Gall Bladder,Cancer, Gallbladder,Cancers, Gall Bladder,Cancers, Gallbladder,Gall Bladder Cancers,Gallbladder Cancers,Gallbladder Neoplasm,Neoplasm, Gallbladder
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D014481 United States A country in NORTH AMERICA between CANADA and MEXICO.

Related Publications

S Jane Henley, and Hannah K Weir, and Melissa A Jim, and Meg Watson, and Lisa C Richardson
December 2018, MMWR. Morbidity and mortality weekly report,
S Jane Henley, and Hannah K Weir, and Melissa A Jim, and Meg Watson, and Lisa C Richardson
July 2013, Chest,
S Jane Henley, and Hannah K Weir, and Melissa A Jim, and Meg Watson, and Lisa C Richardson
October 2017, Environmental health : a global access science source,
S Jane Henley, and Hannah K Weir, and Melissa A Jim, and Meg Watson, and Lisa C Richardson
March 2015, MMWR. Morbidity and mortality weekly report,
S Jane Henley, and Hannah K Weir, and Melissa A Jim, and Meg Watson, and Lisa C Richardson
October 2018, Cancer epidemiology,
S Jane Henley, and Hannah K Weir, and Melissa A Jim, and Meg Watson, and Lisa C Richardson
May 2005, Gynecologic oncology,
S Jane Henley, and Hannah K Weir, and Melissa A Jim, and Meg Watson, and Lisa C Richardson
June 2007, MMWR. Morbidity and mortality weekly report,
S Jane Henley, and Hannah K Weir, and Melissa A Jim, and Meg Watson, and Lisa C Richardson
July 2022, American journal of clinical oncology,
S Jane Henley, and Hannah K Weir, and Melissa A Jim, and Meg Watson, and Lisa C Richardson
October 2024, Urology,
S Jane Henley, and Hannah K Weir, and Melissa A Jim, and Meg Watson, and Lisa C Richardson
October 1996, MMWR. Morbidity and mortality weekly report,
Copied contents to your clipboard!